Key Details
Annual ROE
-102.50%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Mar 10, 2023Recent annual earnings:
Mar 10, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
04 May '21 William Blair
Market Perform13 Apr '21 B of A Securities
Underperform02 Mar '21 William Blair
Outperform02 Mar '21 B of A Securities
NeutralScreeners with LHDX included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Lucira Health doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of Lucira Health?
- What is the ticker symbol for Lucira Health?
- Does Lucira Health pay dividends?
- What sector is Lucira Health in?
- What industry is Lucira Health in?
- What country is Lucira Health based in?
- When did Lucira Health go public?
- Is Lucira Health in the S&P 500?
- Is Lucira Health in the NASDAQ 100?
- Is Lucira Health in the Dow Jones?
- When was Lucira Health's last earnings report?
- When does Lucira Health report earnings?
- Should I buy Lucira Health stock now?
What is the primary business of Lucira Health?
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California. On February 22, 2023, Lucira Health, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
What is the ticker symbol for Lucira Health?
The ticker symbol for Lucira Health is NASDAQ:LHDX
Does Lucira Health pay dividends?
No, Lucira Health does not pay dividends
What sector is Lucira Health in?
Lucira Health is in the Healthcare sector
What industry is Lucira Health in?
Lucira Health is in the Medical Devices industry
What country is Lucira Health based in?
Lucira Health is headquartered in United States
When did Lucira Health go public?
Lucira Health's initial public offering (IPO) was on 04 February 2021
Is Lucira Health in the S&P 500?
No, Lucira Health is not included in the S&P 500 index
Is Lucira Health in the NASDAQ 100?
No, Lucira Health is not included in the NASDAQ 100 index
Is Lucira Health in the Dow Jones?
No, Lucira Health is not included in the Dow Jones index
When was Lucira Health's last earnings report?
Lucira Health's most recent earnings report was on 10 March 2023
When does Lucira Health report earnings?
The date for Lucira Health's next earnings report has not been announced yet
Should I buy Lucira Health stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions